Common Questions

In yet another embarrassing moment for our United States regulatory authorities and medical establishment, doctors in New Zealand have written an open letter published in the New England Journal of Medicine highlighting the extreme danger posed by the drug Pradaxa. As we have written before, Pradaxa is Takeda Pharmaceutical’s solution […]

Bisphosphonates are widely prescribed medications for the treatment and/or prevention of osteoporosis.  The first bisphosphonate (Fosamax, also known as alendronate) for the prevention and/or treatment of osteoporosis was approved for the U.S. market in 1995.  Since that time, four bisphosphonate molecular entities (alendronate sodium, risedronate sodium, ibandronate sodium, and zoledronic […]

Stress imaging tests cost approximately $1,000 each, and are used to measure blood flow to the heart and help determine how well the heart is working at rest and during exercise.  The American College of Cardiology recommends that patients have the test administered two years after having a stent inserted, […]

A startling article entitled, “Conflict of Interest in the Assessment of Thromboprophylaxis” appeared in the January 2012 issue of The Journal of Bone & Joint Surgery. A group of investigators were curious about the possibility of bias during evidence-based reviews and they conducted a retrospective study, centering on prescription choice […]